Neurodegenerative disorders of aging are characterized by the intraneu
ronal accumulation of ubiquitin conjugates into tangles and inclusions
. Ubiquitin conjugates are degraded by cellular particles known as pro
teasomes. We have previously shown that amyloid beta protein (A beta)
inhibits proteasomal activity and thereby blocks ubiquitin conjugate d
egradation. In the present studies, we found that A beta binds the 20
S proteasome and forms a proteasome-A beta complex. The complex was de
tected by Western blot with anti-A beta antibodies. Using a 1.4 nm Nan
ogold-labeled A beta, we visualized proteasome-A beta complexes by sca
nning transmission electron microscopy (STEM). Analysis of the side-on
oriented proteasome-A beta complexes revealed a single gold particle,
corresponding to one gold-labeled A beta, in the middle portion of th
e proteasome. On end-on views of proteasome-A beta complexes, gold was
detected within the area delimited by the proteasome circular project
ion. Both STEM views are consistent with A beta localization inside th
e proteasome along the peptide channel. Direct interaction of A beta w
ith the inner catalytic compartment of the proteasome may explain the
generation of ubiquitin-containing lesions in Alzheimer's disease and
other neurodegenerative disorders. In addition, detection of Nanogold-
labeled peptide inside the 20 S eukaryotic proteasome suggests that co
nformational constraints for protein degradation in eukaryotic proteas
omes are different from those in archaebacteria proteasomes.